Accelerate Diagnostics Inc reports results for the quarter ended in September - Earnings Summary

Accelerate Diagnostics

09/11/2021 22:44

* Accelerate Diagnostics Inc  AXDX.OQ  reported a quarterly
adjusted loss of 15 cents​​ per share for the quarter ended in
September. The mean expectation of five analysts for the quarter
was for a loss of 33 cents per share.
* Revenue fell 13% to $3.12 million from a year ago;  analysts
expected $3.91 million. 
* Accelerate Diagnostics Inc's reported EPS for the quarter was
a loss of 15 cents​.
* The mean earnings estimate of analysts had fallen by
about 0.6% in the last three months.​ 
* In the last 30 days one analyst negatively revised an earnings
estimate 
* Accelerate Diagnostics Inc shares had risen by 5.1% this
quarter and lost 19.1% so far this year.
* The company reported a quarterly loss of $8.99 million.
* Wall Street's median 12-month price target for Accelerate
Diagnostics Inc is $9.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell." 
This summary was machine generated November 9 at 10:44 p.m.
 ​All figures in US dollars unless otherwise stated